| 000 | 01659 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513193849.0 | ||
| 264 | 0 | _c19991116 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/s0049-3848(99)00051-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKinlough-Rathbone, R L | |
| 245 | 0 | 0 |
_aEffects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. _h[electronic resource] |
| 260 |
_bThrombosis research _cSep 1999 |
||
| 300 |
_a315-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBlood Platelets _xmetabolism |
| 650 | 0 | 4 | _aCathepsin G |
| 650 | 0 | 4 |
_aCathepsins _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aHemostatics _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Activating Factor _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIb-IX Complex _xmetabolism |
| 650 | 0 | 4 |
_aRistocetin _xpharmacology |
| 650 | 0 | 4 | _aSerine Endopeptidases |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aThrombin _xpharmacology |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aPerry, D W | |
| 700 | 1 | _aRand, M L | |
| 700 | 1 | _aPackham, M A | |
| 773 | 0 |
_tThrombosis research _gvol. 95 _gno. 6 _gp. 315-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0049-3848(99)00051-1 _zAvailable from publisher's website |
| 999 |
_c10484342 _d10484342 |
||